| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 27 | 2023 | 1654 | 2.680 |
Why?
|
| Hepatitis C, Chronic | 12 | 2018 | 451 | 2.050 |
Why?
|
| Liver Cirrhosis | 15 | 2018 | 944 | 1.900 |
Why?
|
| Hepatitis C | 8 | 2018 | 524 | 1.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2020 | 603 | 0.940 |
Why?
|
| HIV Infections | 12 | 2022 | 2133 | 0.860 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2018 | 2027 | 0.830 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2021 | 38 | 0.800 |
Why?
|
| Liver Neoplasms | 9 | 2018 | 4562 | 0.780 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2018 | 38 | 0.770 |
Why?
|
| Sarcoma, Kaposi | 2 | 2019 | 187 | 0.750 |
Why?
|
| Hepacivirus | 5 | 2017 | 398 | 0.730 |
Why?
|
| Liver Diseases | 4 | 2015 | 570 | 0.710 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 978 | 0.700 |
Why?
|
| Oropharyngeal Neoplasms | 3 | 2023 | 1108 | 0.690 |
Why?
|
| alpha-Fetoproteins | 3 | 2018 | 232 | 0.680 |
Why?
|
| Gastrointestinal Microbiome | 7 | 2023 | 907 | 0.650 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 163 | 0.640 |
Why?
|
| Parkinson Disease | 2 | 2020 | 709 | 0.630 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2019 | 611 | 0.620 |
Why?
|
| Adipokines | 1 | 2018 | 96 | 0.610 |
Why?
|
| Polymorphism, Genetic | 3 | 2015 | 1448 | 0.610 |
Why?
|
| Colon | 5 | 2021 | 673 | 0.580 |
Why?
|
| Algorithms | 5 | 2019 | 3891 | 0.570 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 366 | 0.510 |
Why?
|
| Fatty Liver | 2 | 2012 | 234 | 0.460 |
Why?
|
| Middle Aged | 47 | 2022 | 86494 | 0.450 |
Why?
|
| Diet | 3 | 2019 | 1449 | 0.450 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 3975 | 0.440 |
Why?
|
| Irritable Bowel Syndrome | 3 | 2010 | 203 | 0.440 |
Why?
|
| Body Fat Distribution | 1 | 2012 | 29 | 0.430 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2012 | 20 | 0.420 |
Why?
|
| Finasteride | 1 | 2012 | 31 | 0.420 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 76 | 0.420 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2023 | 5435 | 0.420 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 116 | 0.410 |
Why?
|
| Intestinal Mucosa | 5 | 2023 | 1083 | 0.410 |
Why?
|
| Risk | 5 | 2020 | 1974 | 0.410 |
Why?
|
| Bibliometrics | 1 | 2012 | 71 | 0.410 |
Why?
|
| Peer Review, Research | 1 | 2012 | 66 | 0.410 |
Why?
|
| Narcotics | 1 | 2012 | 123 | 0.400 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 279 | 0.400 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 1066 | 0.380 |
Why?
|
| Vitamin D | 1 | 2013 | 260 | 0.380 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 428 | 0.380 |
Why?
|
| United States | 22 | 2022 | 15562 | 0.380 |
Why?
|
| Adiposity | 1 | 2012 | 238 | 0.380 |
Why?
|
| Risk Factors | 20 | 2023 | 17611 | 0.380 |
Why?
|
| Methadone | 1 | 2012 | 195 | 0.370 |
Why?
|
| Electronic Health Records | 2 | 2019 | 928 | 0.370 |
Why?
|
| Cross-Sectional Studies | 13 | 2022 | 4328 | 0.370 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 624 | 0.360 |
Why?
|
| Humans | 78 | 2023 | 262220 | 0.360 |
Why?
|
| Spouse Abuse | 1 | 2009 | 22 | 0.360 |
Why?
|
| Gastroenterology | 1 | 2012 | 194 | 0.350 |
Why?
|
| Postmenopause | 5 | 2018 | 377 | 0.350 |
Why?
|
| Sex Offenses | 1 | 2010 | 51 | 0.350 |
Why?
|
| Case-Control Studies | 8 | 2021 | 6104 | 0.350 |
Why?
|
| Caffeine | 2 | 2023 | 87 | 0.340 |
Why?
|
| Barrett Esophagus | 4 | 2020 | 567 | 0.340 |
Why?
|
| Feeding Behavior | 2 | 2015 | 810 | 0.330 |
Why?
|
| Bacteria | 4 | 2022 | 611 | 0.320 |
Why?
|
| Incidence | 9 | 2022 | 5712 | 0.320 |
Why?
|
| Male | 40 | 2022 | 123293 | 0.310 |
Why?
|
| Aggression | 1 | 2009 | 252 | 0.300 |
Why?
|
| Aged | 27 | 2020 | 70357 | 0.290 |
Why?
|
| Testosterone | 1 | 2011 | 620 | 0.290 |
Why?
|
| Sex Factors | 5 | 2019 | 2155 | 0.290 |
Why?
|
| Motor Activity | 1 | 2010 | 693 | 0.280 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 357 | 0.280 |
Why?
|
| Inflammation | 4 | 2020 | 2514 | 0.280 |
Why?
|
| Coffee | 3 | 2023 | 33 | 0.280 |
Why?
|
| Obesity | 4 | 2022 | 2892 | 0.280 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 404 | 0.280 |
Why?
|
| Disease Progression | 3 | 2022 | 6696 | 0.270 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 529 | 0.260 |
Why?
|
| Female | 40 | 2022 | 142255 | 0.260 |
Why?
|
| Esophageal Neoplasms | 5 | 2020 | 3170 | 0.260 |
Why?
|
| Prevalence | 7 | 2020 | 3270 | 0.250 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 10348 | 0.250 |
Why?
|
| Persian Gulf Syndrome | 1 | 2023 | 14 | 0.230 |
Why?
|
| Adult | 22 | 2023 | 78112 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2018 | 5101 | 0.230 |
Why?
|
| Immunogenetics | 1 | 2023 | 17 | 0.230 |
Why?
|
| Prospective Studies | 12 | 2021 | 12923 | 0.220 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 62 | 0.220 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 10 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2023 | 486 | 0.210 |
Why?
|
| Age Factors | 5 | 2019 | 5385 | 0.210 |
Why?
|
| HIV | 2 | 2021 | 229 | 0.210 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 553 | 0.210 |
Why?
|
| Sleep | 2 | 2017 | 414 | 0.210 |
Why?
|
| Surveys and Questionnaires | 7 | 2023 | 5713 | 0.210 |
Why?
|
| Interleukins | 2 | 2015 | 327 | 0.200 |
Why?
|
| Hyperlipidemias | 1 | 2023 | 236 | 0.200 |
Why?
|
| Tooth Loss | 1 | 2020 | 4 | 0.190 |
Why?
|
| Risk Assessment | 7 | 2019 | 6896 | 0.190 |
Why?
|
| Antiviral Agents | 3 | 2017 | 1234 | 0.190 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2018 | 420 | 0.190 |
Why?
|
| Principal Component Analysis | 2 | 2018 | 220 | 0.190 |
Why?
|
| Periodontal Diseases | 1 | 2020 | 23 | 0.190 |
Why?
|
| Logistic Models | 3 | 2013 | 3450 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 1 | 2023 | 549 | 0.180 |
Why?
|
| Registries | 2 | 2019 | 2188 | 0.180 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2017 | 16 | 0.180 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 210 | 0.180 |
Why?
|
| Patient Readmission | 2 | 2015 | 552 | 0.180 |
Why?
|
| Comorbidity | 4 | 2020 | 2394 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2010 | 2326 | 0.180 |
Why?
|
| Geography | 1 | 2019 | 141 | 0.170 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 188 | 0.170 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 171 | 0.170 |
Why?
|
| Anti-HIV Agents | 1 | 2022 | 351 | 0.170 |
Why?
|
| Health Services Administration | 1 | 2018 | 13 | 0.160 |
Why?
|
| Plasminogen Inactivators | 1 | 2018 | 9 | 0.160 |
Why?
|
| Gout | 1 | 2021 | 140 | 0.160 |
Why?
|
| HIV Protease Inhibitors | 1 | 2018 | 72 | 0.160 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 226 | 0.160 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 56 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2022 | 38020 | 0.150 |
Why?
|
| Adiponectin | 1 | 2018 | 162 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 196 | 0.150 |
Why?
|
| Anus Neoplasms | 1 | 2021 | 412 | 0.150 |
Why?
|
| Receptors, Ghrelin | 1 | 2016 | 35 | 0.140 |
Why?
|
| Databases, Factual | 3 | 2020 | 2236 | 0.140 |
Why?
|
| Mexican Americans | 1 | 2018 | 322 | 0.140 |
Why?
|
| Leptin | 1 | 2018 | 295 | 0.140 |
Why?
|
| Ghrelin | 1 | 2016 | 79 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 4976 | 0.140 |
Why?
|
| Nutritional Sciences | 1 | 2016 | 68 | 0.140 |
Why?
|
| Cohort Studies | 8 | 2022 | 9288 | 0.140 |
Why?
|
| Hypertension | 2 | 2023 | 1514 | 0.140 |
Why?
|
| Psychiatric Rehabilitation | 1 | 2015 | 8 | 0.130 |
Why?
|
| Alcohol Abstinence | 1 | 2015 | 17 | 0.130 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 560 | 0.130 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 40 | 0.130 |
Why?
|
| Bias | 2 | 2013 | 206 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2020 | 297 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 1826 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 6042 | 0.120 |
Why?
|
| ROC Curve | 1 | 2017 | 1180 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 346 | 0.120 |
Why?
|
| Hospitals, Veterans | 2 | 2018 | 399 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 543 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 1360 | 0.120 |
Why?
|
| Young Adult | 4 | 2019 | 21503 | 0.120 |
Why?
|
| Health Education | 1 | 2016 | 309 | 0.120 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 4348 | 0.120 |
Why?
|
| Adenocarcinoma | 4 | 2020 | 7793 | 0.120 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 255 | 0.120 |
Why?
|
| Diet Records | 1 | 2013 | 77 | 0.110 |
Why?
|
| Colorectal Surgery | 1 | 2013 | 32 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 29996 | 0.110 |
Why?
|
| Fructose | 1 | 2013 | 72 | 0.110 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2012 | 40 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2015 | 310 | 0.110 |
Why?
|
| Hepatitis | 1 | 2013 | 93 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2015 | 295 | 0.110 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 135 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 289 | 0.110 |
Why?
|
| Disease Management | 1 | 2018 | 1061 | 0.110 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 1947 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2018 | 790 | 0.100 |
Why?
|
| Optical Imaging | 1 | 2013 | 157 | 0.100 |
Why?
|
| Neurofibrillary Tangles | 1 | 1991 | 24 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 4323 | 0.100 |
Why?
|
| Endosonography | 1 | 2014 | 536 | 0.100 |
Why?
|
| Data Collection | 2 | 2010 | 625 | 0.090 |
Why?
|
| Endemic Diseases | 1 | 2010 | 67 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 601 | 0.090 |
Why?
|
| Vietnam Conflict | 1 | 2009 | 9 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 2207 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 2213 | 0.090 |
Why?
|
| Vietnam | 1 | 2009 | 56 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 479 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 4902 | 0.090 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2009 | 105 | 0.090 |
Why?
|
| Afghan Campaign 2001- | 1 | 2009 | 110 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 4788 | 0.090 |
Why?
|
| Viral Load | 1 | 2011 | 492 | 0.090 |
Why?
|
| Mass Screening | 1 | 2018 | 1505 | 0.090 |
Why?
|
| Hepatitis B | 2 | 2010 | 259 | 0.090 |
Why?
|
| Neoplasms | 4 | 2021 | 15198 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 3583 | 0.080 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 1251 | 0.080 |
Why?
|
| Proportional Hazards Models | 4 | 2019 | 5010 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2015 | 5539 | 0.080 |
Why?
|
| Papillomaviridae | 2 | 2022 | 612 | 0.080 |
Why?
|
| Dyspepsia | 1 | 2008 | 103 | 0.080 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2007 | 69 | 0.080 |
Why?
|
| Feces | 2 | 2021 | 772 | 0.070 |
Why?
|
| Unsafe Sex | 1 | 2007 | 21 | 0.070 |
Why?
|
| Military Personnel | 1 | 2009 | 224 | 0.070 |
Why?
|
| Biomarkers | 3 | 2018 | 5057 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2013 | 1177 | 0.070 |
Why?
|
| Time Factors | 3 | 2017 | 12980 | 0.070 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 2282 | 0.070 |
Why?
|
| Methamphetamine | 1 | 2007 | 61 | 0.070 |
Why?
|
| Quality of Life | 3 | 2009 | 4578 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2007 | 756 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2010 | 557 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2007 | 256 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 4556 | 0.070 |
Why?
|
| Medical Records | 1 | 2007 | 414 | 0.070 |
Why?
|
| Coinfection | 2 | 2017 | 189 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2007 | 608 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 223 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 2631 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2007 | 230 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 324 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 1329 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 433 | 0.060 |
Why?
|
| Genotype | 2 | 2013 | 4108 | 0.060 |
Why?
|
| Gulf War | 1 | 2023 | 8 | 0.060 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 7 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 899 | 0.060 |
Why?
|
| Protective Devices | 1 | 2003 | 21 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 1991 | 857 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 2017 | 330 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 587 | 0.060 |
Why?
|
| Texas | 2 | 2012 | 6309 | 0.060 |
Why?
|
| Aging | 1 | 1991 | 1534 | 0.050 |
Why?
|
| Interferons | 2 | 2015 | 290 | 0.050 |
Why?
|
| Nurses | 1 | 2003 | 82 | 0.050 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2022 | 71 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 94 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2022 | 61 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2003 | 132 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 601 | 0.050 |
Why?
|
| Verrucomicrobia | 1 | 2021 | 26 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2019 | 1550 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2008 | 995 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2003 | 158 | 0.050 |
Why?
|
| Knee Joint | 1 | 2022 | 170 | 0.050 |
Why?
|
| Oral Health | 1 | 2020 | 19 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2020 | 46 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 146 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 241 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2022 | 342 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 1562 | 0.050 |
Why?
|
| Sample Size | 2 | 2013 | 203 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 847 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2021 | 33017 | 0.040 |
Why?
|
| Food Analysis | 1 | 2019 | 28 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 450 | 0.040 |
Why?
|
| Weight Gain | 1 | 2022 | 464 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2018 | 44 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 645 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 85 | 0.040 |
Why?
|
| Heart Failure | 2 | 2016 | 2523 | 0.040 |
Why?
|
| Smoking | 2 | 2019 | 2444 | 0.040 |
Why?
|
| Edible Grain | 1 | 2018 | 55 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2019 | 302 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 130 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2013 | 5567 | 0.040 |
Why?
|
| Protective Factors | 1 | 2018 | 107 | 0.040 |
Why?
|
| Platelet Count | 1 | 2018 | 490 | 0.040 |
Why?
|
| Prognosis | 1 | 2015 | 21744 | 0.040 |
Why?
|
| Body Weight | 1 | 2022 | 1292 | 0.040 |
Why?
|
| Radiography | 1 | 2022 | 1899 | 0.040 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1998 | 82 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 559 | 0.040 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 137 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 165 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 1000 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 615 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 928 | 0.040 |
Why?
|
| Women's Health | 1 | 2017 | 206 | 0.030 |
Why?
|
| Fruit | 1 | 2018 | 297 | 0.030 |
Why?
|
| Paris | 1 | 2015 | 10 | 0.030 |
Why?
|
| Vegetables | 1 | 2018 | 326 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2015 | 173 | 0.030 |
Why?
|
| Phenotype | 2 | 2022 | 6259 | 0.030 |
Why?
|
| Survival Rate | 2 | 2020 | 12240 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 766 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 170 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 339 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 7719 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 151 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 756 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 604 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 2480 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 3447 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2013 | 206 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 31262 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 1869 | 0.030 |
Why?
|
| Amyloid | 1 | 1991 | 96 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 1267 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2010 | 24 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 205 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 1165 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2010 | 104 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 1292 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 486 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 1929 | 0.020 |
Why?
|
| Autonomic Agents | 1 | 2008 | 3 | 0.020 |
Why?
|
| Selenoproteins | 1 | 2008 | 17 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 14907 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 1014 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2008 | 37 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2008 | 425 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 162 | 0.020 |
Why?
|
| Brain Mapping | 1 | 1991 | 647 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1026 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 1098 | 0.020 |
Why?
|
| Surgery, Plastic | 1 | 1993 | 344 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 160 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2012 | 729 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2008 | 252 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2008 | 226 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2008 | 245 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 180 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 2061 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2362 | 0.020 |
Why?
|
| Hippocampus | 1 | 1991 | 921 | 0.020 |
Why?
|
| Global Health | 1 | 2010 | 665 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 59491 | 0.020 |
Why?
|
| Antioxidants | 1 | 2008 | 512 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 1155 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 465 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 1887 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 875 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 87 | 0.010 |
Why?
|
| Time | 1 | 2003 | 179 | 0.010 |
Why?
|
| Inservice Training | 1 | 2003 | 76 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 121 | 0.010 |
Why?
|
| Organizational Culture | 1 | 2003 | 107 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 7567 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2007 | 556 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2007 | 667 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1993 | 1411 | 0.010 |
Why?
|
| Myocardium | 1 | 2008 | 1295 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 1545 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1991 | 7545 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 13670 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 2823 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1998 | 228 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 3757 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1998 | 544 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 1215 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1998 | 2801 | 0.010 |
Why?
|